Adobe Investment Case Summary
Adobe investment case summary.
Friday, August 21
Everything we published on this day.
46 stories — the front page that day →
Adobe investment case summary.
Re/Max’s outstanding share count is revised after previously omitted shares under its holding-company structure, alongside updated Real…
Real Brokerage’s RE/MAX acquisition would triple its agent count, diversify revenue with franchise fees and expand share during a weak U.S.
Adobe’s investment case centers on its software business.
Stabilis Solutions lost its Galveston LNG offtake anchor, revenue fell 36% in 1H’26, and limited liquidity leaves its data-center power…
Deere raised net income and cash flow guidance despite a 10% Production and Precision Ag sales decline, as construction and small-ag…
Interesting observation: $LULU and $9992 have nearly the same near-term EBITDA and a similar young, female-dominated consumer base, yet one company trades at twice the valuation of the other. Looking three years out, which company do you think will have higher earnings? https://t.co/csPJuZDeRS https://t.co/mehKT22dYA
Modine's leaked database identifies Google behind a $4 billion agreement and $4.5 billion of additional demand, with nearly $15 billion of…
Synchrony Financial $SYF popped a new buyback to the tune of $6.5bn, roughly 24% of its market cap. This one has been and remains a true share cannibal. https://t.co/c4cbOsC4jk
Global Payments $GPN approved a $2.5bn buyback, including a $550m in accelerated purchases, and expects to return over $2bn to shareholders in 2026. The target is still $7.5b in capital returns through 2027. Nice. And what’s also nice is the msd topline growth and 150bps margin expansion guided for this year. c. 6.5x 2026 EV/EBITDA.
TSOH Weekly Roundup covers Walmart’s soft U.S. comps and rapid delivery, Qiaodan’s challenge to Nike in China, and Suno’s AI-generated…
Intercontinental Exchange combines high-margin exchanges, recurring data services and mortgage technology, trading at about 18 times 2027…
Blog post alert: $MRNA https://t.co/32w6RYXr0p
@WaterworldCapi1 @tierrapartners $ARQQ and $BTQ as well.
$MRNA - Who wants to hold this over the weekend after the week it had and potential secondary overhang?
@ShmuelLon I actually don't think $PFF is the best expression of this trade, I'm just using it here cause it's got a long track record. But I've been going through the securities in stuff like $PGC and $PGF and I think as a basket they're very attractive.
Heres a portfolio that's 80% $SPY, $70% $TLT, -70% $PFF, 20% $GLD. Similar return with way lower volatility. Obviously this is just backwards looking, but there are structural reasons why this kind of mix works (Preferred stocks suck, most of the alpha is there). https://t.co/pfsyWJG2f2
My largest short is $PFFD a preferred ETF, but I'm switching the exposure to $PGF. Even though it's 2% borrow vs 1% for PFFD, PFFD has 25% exposure to mandatory convertibles that essentially act as equity. Meanwhile PGF is full of low yield, perpetual, callable preferreds, which
@taobanker This is reasonable. I guess the counter would be that current business momentum is much stronger than at least $LULU, I haven't looked at Gap or BBW
$APP price now under when Muddy Waters released a short report on the stock last year. https://t.co/U3w8oUnomI https://t.co/SS1Mp9vjRi
$DECK back at multi year low valuations but concern is the classic value trap risk that margins and ROC are at cyclical peaks. Growth has really fallen off too from 15-18% in 2023-2025 to just 7% in 2026. https://t.co/jvT5HnDjnH
@GHadjia @MattJMcClintock Growth has been coming off fast at $DECK no? https://t.co/NvAKB2OyqN
@nkreu113r Somewhat at odds with $DXYZ up like 50% this month.
All that complexity and blow-up risk to clone $SPY's returns in a bull market? https://t.co/kYImPyU49M
@MrDestruct_007 have not traded $VASO in a while. Need to catch up on it.
$SUJA just under $9m in purchases from Paine Schwartz, telegraphed beforehand with a press release.👀 https://t.co/nwmFTEx0kE https://t.co/wUTLfBKL2p
Looks like $KLNG is winning the subsea battle vs. $MIND. https://t.co/WCc2il0NhZ
It’s happening… Seller’s remorse is starting to set in for trigger-happy $KLNG shareholders. I have a feeling the same will happen to $SIF panic sellers who blindly accepted “horrendous” GAAP EPS as true earnings power. Lesson 👉 Read the transcripts & do your own math. https://t.co/0u7pxLVft4
$BTC is at $77k. You can just buy hated stuff and tell the market to suck your balls. https://t.co/ZmzYHBZLoA
@be4_the_h3rd @JasperRidley $xgn just getting started imo
@taobanker Good chance this will be another 14% higher at some point between now and Dec. Things in motion stay in motion... $COLO https://t.co/CjrbroM2R3
@BoxLongs Wild truth is that if $SNAP chooses they can earn over $1/share in FCF next year. $5 stock.
Bought $TTWO after seeing the GTA VI leaked footage. Forget the graphics. Unpolished gameplay is showing a massive leap in world density, NPC behavior and systemic depth. The world feels alive. First real evidence GTA VI may actually be a generational leap. That’s the signal. https://t.co/r6HKMVSYgc
@taobanker $U up every day, $APP down every day, $RBLX demolished. Things as they should be.
@2suns2moons @bold_perception $CIB dividend up from $2.25/year in 2022 to more than $6/share now. Covers a lot of living expenses. If you relocate to another country, good to own some stuff there so you have an economic stake if its conditions improve...
SOXX holdings Nvidia, AMD and Broadcom signal slowing growth and peak-margin risk after the sector’s steep July selloff.
Reviewing some expert transcripts. On $XGN this is worth flagging. The Rheumatologist being interviewed confirms the bull thesis. Says he uses AVISE (XGN) for his panels bc generic tests don't work well in autoimmune, and AVISE more accurate. Flat out says that the one autoimmune marker XGN doesn't offer is for Myositis, where he uses another lab. Guess what $XGN is offering in 2027?
Walmart says Medicare Maximum Fair Price rules will cut FY27 US comps by 125 basis points, while pharmacy margins and prescription volumes…
Vistance Networks trades at $11 after a $5 special distribution, with a DOCSIS 4.0 upgrade cycle, cash reserves and a $160 million tax…
Palantir’s revenue rose 93% to $1.94 billion as U.S. commercial bookings jumped 149%, lifting GAAP operating margin to 47% and free cash…
Deutsche Bank $DB freed from consent order in 2010s FX scandal https://t.co/BsHGBheaWK
IRhythm’s ZEUS clearance cuts clinician review time 50%, targeting $100 million in five-year savings as cardiac monitoring margins expand…
GlobalFoundries' data center revenue rose 62% year over year as rising capex for quantum and silicon photonics increases near-term cash…
Palantir's U.S. commercial business grew triple digits as GAAP net margins rose from under 10% to 55%, countering Michael Burry's bearish…
Corcept Therapeutics expects Lifyorli and Korlym to support 44% revenue growth, while FDA and European decisions on relacorilant could…
@finphysnerd @taobanker A sentiment check on X searching $DECK, its universally positive except @CatNyanpital who is the only bearish comments on this name. Doesn't mean it can't work though